People On The Move: Appointments At Futura Medical, Bayer And Maxwellia
Executive Summary
The latest appointments in Europe's consumer health industry: Former Perrigo exec Jeff Needham joins Futura Medical; Bayer promotes Gomez to lead Swiss Consumer business; and Maxwellia appoints Al-Attbi to newly-created role.
You may also be interested in...
Futura Strikes Deal To Commercialize Erectile Dysfunction Gel In Middle East
UK R&D firm Futura Medical strikes third commercial agreement for its drug-free erectile dysfunction treatment MED3000, this time with Switzerland’s Labatec Pharma, which will take the drug-free gel to the Middle East.
Futura Takes Drug-Free Erectile Dysfunction Gel To Latin America
UK based Futura Medical has struck a deal with m8 Pharmaceuticals to take its drug-free erectile dysfunction gel to Brazil and Mexico.
Futura’s Drug-Free Erectile Dysfunction Gel On Track For US And EU Launch
Futura Medical's latest meeting with the FDA puts the UK start-up one step closer to launching its drug-free erectile dysfunction gel MED3000 in the US in 2023, while the firm gets ready to launch in the EU next year following its recent CE-mark approval.